| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.835 | 0.007 | 0.86 | Caspase 9 stimulant | 0.86 0.005 CID_124202107 | CID_124202107 | |
| 0.737 | 0.005 | 0.823 | Free radical scavenger | 0.823 0.004 CID_124202107 | CID_124202107 | |
| 0.731 | 0.004 | 0.731 | Superoxide dismutase inhibitor | 0.203 0.114 CID_124202107 | ||
| 0.724 | 0.005 | 0.724 | Amyloid beta aggregation inhibitor | 0.551 0.01 CID_124202107 | ||
| 0.742 | 0.024 | 0.847 | Apoptosis agonist | 0.847 0.011 CID_124202107 | CID_124202107 | |
| 0.719 | 0.005 | 0.861 | Antioxidant | 0.861 0.004 CID_124202107 | CID_124202107 | |
| 0.695 | 0.021 | 0.917 | Transcription factor NF kappa B inhibitor | 0.917 0.005 CID_124202107 | CID_124202107 | |
| 0.628 | 0.003 | 0.628 | Cystathionine beta-synthase inhibitor | 0.445 0.004 CID_124202107 | ||
| 0.631 | 0.013 | 0.631 | Vasodilator, peripheral | 0.54 0.022 CID_124202107 | ||
| 0.626 | 0.008 | 0.626 | Lipoxygenase inhibitor | |||
| 0.611 | 0.002 | 0.611 | Succinate dehydrogenase inhibitor | 0.195 0.053 CID_124202107 | ||
| 0.609 | 0.018 | 0.609 | Aldehyde oxidase inhibitor | |||
| 0.594 | 0.005 | 0.869 | Monophenol monooxygenase inhibitor | 0.869 0.002 CID_124202107 | CID_124202107 | |
| 0.591 | 0.02 | 0.756 | Cholesterol antagonist | 0.756 0.005 CID_124202107 | CID_124202107 | |
| 0.578 | 0.012 | 0.625 | Apoptosis antagonist | 0.625 0.007 CID_124202107 | CID_124202107 | |
| 0.562 | 0.003 | 0.562 | Carbonic anhydrase VI inhibitor | 0.267 0.008 CID_124202107 | ||
| 0.561 | 0.004 | 0.791 | Amylase inhibitor | 0.791 0.002 CID_124202107 | CID_124202107 | |
| 0.552 | 0.005 | 0.552 | NOS3 expression enhancer | 0.54 0.005 CID_124202107 | ||
| 0.543 | 0.005 | 0.717 | Melanin inhibitor | 0.717 0.003 CID_124202107 | CID_124202107 | |
| 0.59 | 0.056 | 0.842 | Antiinflammatory | 0.842 0.01 CID_124202107 | CID_124202107 | |
| 0.537 | 0.013 | 0.742 | Antiamyloidogenic | 0.742 0.004 CID_124202107 | CID_124202107 | |
| 0.523 | 0.017 | 0.523 | Caspase 3 stimulant | 0.483 0.023 CID_124202107 | ||
| 0.521 | 0.022 | 0.521 | Histamine release inhibitor | 0.518 0.023 CID_124202107 | ||
| 0.519 | 0.027 | 0.76 | Antithrombotic | 0.76 0.005 CID_124202107 | CID_124202107 | |
| 0.501 | 0.009 | 0.501 | Peroxidase inhibitor | |||
| 0.493 | 0.003 | 0.493 | Carbonic anhydrase III inhibitor | 0.24 0.01 CID_124202107 | ||
| 0.47 | 0.004 | 0.47 | HIV-1 integrase (3'-Processing) inhibitor | 0.275 0.005 CID_124202107 | ||
| 0.468 | 0.003 | 0.468 | Keratolytic | 0.131 0.018 CID_124202107 | ||
| 0.47 | 0.006 | 0.564 | Platelet adhesion inhibitor | 0.564 0.004 CID_124202107 | CID_124202107 | |
| 0.471 | 0.009 | 0.471 | Tubulin antagonist | 0.188 0.041 CID_124202107 | ||
| 0.474 | 0.016 | 0.588 | DNA damaging | 0.588 0.009 CID_124202107 | CID_124202107 | |
| 0.495 | 0.041 | 0.495 | 15-Lipoxygenase inhibitor | |||
| 0.456 | 0.004 | 0.456 | Carbonic anhydrase XIII inhibitor | 0.318 0.005 CID_124202107 | ||
| 0.465 | 0.019 | 0.634 | Hypoglycemic | 0.634 0.006 CID_124202107 | CID_124202107 | |
| 0.451 | 0.011 | 0.451 | Anesthetic general | 0.365 0.021 CID_124202107 | ||
| 0.453 | 0.017 | 0.453 | Antimitotic | 0.363 0.029 CID_124202107 | ||
| 0.445 | 0.014 | 0.445 | Pyruvate kinase inhibitor | 0.145 0.119 CID_124202107 | ||
| 0.436 | 0.006 | 0.456 | DNA methyltransferase I inhibitor | 0.456 0.005 CID_124202107 | CID_124202107 | |
| 0.427 | 0.008 | 0.518 | Lipid peroxidase inhibitor | 0.518 0.005 CID_124202107 | CID_124202107 | |
| 0.437 | 0.021 | 0.671 | Nitric oxide antagonist | 0.671 0.007 CID_124202107 | CID_124202107 | |
| 0.436 | 0.026 | 0.705 | Vasodilator, coronary | 0.705 0.004 CID_124202107 | CID_124202107 | |
| 0.398 | 0.004 | 0.398 | HIV-1 integrase (Strand Transfer) inhibitor | 0.247 0.006 CID_124202107 | ||
| 0.402 | 0.011 | 0.492 | DNA methylase inhibitor | 0.492 0.006 CID_124202107 | CID_124202107 | |
| 0.394 | 0.005 | 0.631 | Expectorant | 0.631 0.003 CID_124202107 | CID_124202107 | |
| 0.396 | 0.008 | 0.396 | Tyrosine 3 hydroxylase inhibitor | |||
| 0.388 | 0.004 | 0.388 | Histidine decarboxylase inhibitor | |||
| 0.416 | 0.035 | 0.416 | 12-Lipoxygenase inhibitor | |||
| 0.403 | 0.024 | 0.403 | Calcium channel activator | |||
| 0.402 | 0.027 | 0.602 | Tumour necrosis factor alpha release inhibitor | 0.602 0.007 CID_124202107 | CID_124202107 | |
| 0.386 | 0.018 | 0.417 | P-glycoprotein inhibitor | 0.417 0.014 CID_124202107 | CID_124202107 | |
| 0.368 | 0.006 | 0.368 | GABA C receptor agonist | |||
| 0.387 | 0.025 | 0.509 | Vasodilator | 0.509 0.011 CID_124202107 | CID_124202107 | |
| 0.352 | 0.004 | 0.352 | Prostaglandin EP2 antagonist | 0.113 0.016 CID_124202107 | ||
| 0.354 | 0.007 | 0.354 | Cholesterol synthesis inhibitor | 0.221 0.022 CID_124202107 | ||
| 0.382 | 0.035 | 0.382 | Hypoxia-inducible factor 1 alpha inhibitor | 0.38 0.036 CID_124202107 | ||
| 0.353 | 0.007 | 0.353 | 5-Lipoxygenase inhibitor | |||
| 0.361 | 0.018 | 0.555 | Non-steroidal antiinflammatory agent | 0.555 0.005 CID_124202107 | CID_124202107 | |
| 0.372 | 0.033 | 0.389 | Platelet antagonist | 0.389 0.029 CID_124202107 | CID_124202107 | |
| 0.419 | 0.081 | 0.725 | Cyclophilin D inhibitor | 0.725 0.012 CID_124202107 | CID_124202107 | |
| 0.354 | 0.018 | 0.586 | Hepatoprotectant | 0.586 0.005 CID_124202107 | CID_124202107 | |
| 0.34 | 0.008 | 0.34 | Chelator | 0.147 0.037 CID_124202107 | ||
| 0.339 | 0.014 | 0.339 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.211 0.064 CID_124202107 | ||
| 0.424 | 0.105 | 0.822 | Alpha-glucosidase inhibitor | 0.822 0.016 CID_124202107 | CID_124202107 | |
| 0.325 | 0.009 | 0.325 | DNA polymerase I inhibitor | 0.278 0.013 CID_124202107 | ||
| 0.395 | 0.079 | 0.678 | Antibacterial | 0.678 0.01 CID_124202107 | CID_124202107 | |
| 0.329 | 0.014 | 0.448 | Protein kinase stimulant | 0.448 0.005 CID_124202107 | CID_124202107 | |
| 0.345 | 0.034 | 0.345 | Transcription factor STAT3 inhibitor | 0.241 0.09 CID_124202107 | ||
| 0.345 | 0.034 | 0.792 | Angiogenesis stimulant | 0.792 0.004 CID_124202107 | CID_124202107 | |
| 0.316 | 0.007 | 0.497 | Mediator release inhibitor | 0.497 0.004 CID_124202107 | CID_124202107 | |
| 0.338 | 0.029 | 0.338 | 5 Hydroxytryptamine uptake stimulant | |||
| 0.348 | 0.041 | 0.348 | Sodium/bile acid cotransporter inhibitor | 0.213 0.171 CID_124202107 | ||
| 0.32 | 0.016 | 0.32 | Protein-tyrosine phosphatase inhibitor | 0.214 0.042 CID_124202107 | ||
| 0.316 | 0.013 | 0.316 | Insulin sensitizer | 0.207 0.066 CID_124202107 | ||
| 0.352 | 0.05 | 0.352 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | |||
| 0.305 | 0.004 | 0.305 | Macrophage migration inhibitory factor inhibitor | |||
| 0.337 | 0.039 | 0.337 | Insulysin inhibitor | |||
| 0.301 | 0.007 | 0.486 | Xanthine oxidase inhibitor | 0.486 0.004 CID_124202107 | CID_124202107 | |
| 0.309 | 0.017 | 0.309 | Phospholipase C inhibitor | 0.209 0.039 CID_124202107 | ||
| 0.287 | 0.006 | 0.287 | Mannose-6-phosphate isomerase inhibitor | 0.261 0.01 CID_124202107 | ||
| 0.374 | 0.096 | 0.374 | 5 Hydroxytryptamine release inhibitor | 0.334 0.13 CID_124202107 | ||
| 0.359 | 0.082 | 0.558 | Immunosuppressant | 0.558 0.019 CID_124202107 | CID_124202107 | |
| 0.282 | 0.005 | 0.282 | Toll-Like receptor 2 antagonist | 0.169 0.04 CID_124202107 | ||
| 0.294 | 0.019 | 0.294 | Amyloid beta precursor protein antagonist | |||
| 0.291 | 0.017 | 0.345 | Alpha-N-acetylglucosaminidase inhibitor | 0.345 0.012 CID_124202107 | CID_124202107 | |
| 0.287 | 0.019 | 0.352 | Topoisomerase II inhibitor | 0.352 0.013 CID_124202107 | CID_124202107 | |
| 0.278 | 0.014 | 0.278 | Interleukin 1 antagonist | 0.175 0.044 CID_124202107 | ||
| 0.272 | 0.009 | 0.364 | ATPase inhibitor | 0.364 0.004 CID_124202107 | CID_124202107 | |
| 0.285 | 0.022 | 0.467 | Interferon gamma antagonist | 0.467 0.008 CID_124202107 | CID_124202107 | |
| 0.269 | 0.007 | 0.269 | Catalase inhibitor | |||
| 0.266 | 0.005 | 0.266 | Beta tubulin antagonist | |||
| 0.264 | 0.005 | 0.264 | Vanilloid 1 agonist | 0.214 0.009 CID_124202107 | ||
| 0.267 | 0.011 | 0.267 | Interleukin 1b antagonist | 0.167 0.03 CID_124202107 | ||
| 0.26 | 0.004 | 0.26 | Heat shock protein 70 antagonist | 0.186 0.009 CID_124202107 | ||
| 0.299 | 0.044 | 0.415 | DNA synthesis inhibitor | 0.415 0.02 CID_124202107 | CID_124202107 | |
| 0.306 | 0.052 | 0.306 | Transcription factor STAT inhibitor | 0.18 0.168 CID_124202107 | ||
| 0.301 | 0.048 | 0.429 | Interleukin agonist | 0.429 0.015 CID_124202107 | CID_124202107 | |
| 0.257 | 0.004 | 0.257 | Carbonic anhydrase V inhibitor | |||
| 0.256 | 0.006 | 0.256 | NAD(P)H dehydrogenase (quinone) inhibitor | 0.071 0.06 CID_124202107 | ||
| 0.252 | 0.004 | 0.361 | Carbonic anhydrase XIV inhibitor | 0.361 0.003 CID_124202107 | CID_124202107 | |
| 0.261 | 0.014 | 0.424 | Cell adhesion inhibitor | 0.424 0.005 CID_124202107 | CID_124202107 | |
| 0.271 | 0.024 | 0.271 | Tumour necrosis factor antagonist | |||
| 0.288 | 0.041 | 0.288 | Sigma receptor agonist | |||
| 0.247 | 0.004 | 0.247 | Glutamate decarboxylase inhibitor | |||
| 0.246 | 0.006 | 0.246 | ABCA1 expression enhancer | |||
| 0.289 | 0.05 | 0.289 | Interleukin antagonist | |||
| 0.27 | 0.035 | 0.27 | Dual specificity phosphatase 3 inhibitor | |||
| 0.26 | 0.026 | 0.26 | Nitric-oxide synthase stimulant | 0.242 0.038 CID_124202107 | ||
| 0.235 | 0.008 | 0.235 | Mucolytic | 0.2 0.013 CID_124202107 | ||
| 0.282 | 0.055 | 0.369 | Hypolipemic | 0.369 0.031 CID_124202107 | CID_124202107 | |
| 0.237 | 0.012 | 0.267 | Microtubule formation inhibitor | 0.267 0.005 CID_124202107 | CID_124202107 | |
| 0.242 | 0.018 | 0.242 | Protein-tyrosine phosphatase 1B inhibitor | 0.197 0.03 CID_124202107 | ||
| 0.246 | 0.022 | 0.246 | Cyclooxygenase 1 inhibitor | 0.187 0.04 CID_124202107 | ||
| 0.257 | 0.035 | 0.257 | Neurotrophic factor enhancer | 0.185 0.092 CID_124202107 | ||
| 0.226 | 0.004 | 0.226 | Carbonic anhydrase VA inhibitor | |||
| 0.225 | 0.004 | 0.225 | Glutathione S-transferase inhibitor | |||
| 0.252 | 0.035 | 0.252 | Mcl-1 antagonist | |||
| 0.225 | 0.01 | 0.225 | Estrogen antagonist | 0.113 0.068 CID_124202107 | ||
| 0.24 | 0.026 | 0.24 | Phospholipase A2 inhibitor | 0.164 0.063 CID_124202107 | ||
| 0.286 | 0.074 | 0.286 | 5 Hydroxytryptamine release stimulant | 0.211 0.112 CID_124202107 | ||
| 0.216 | 0.004 | 0.216 | Ornithine decarboxylase inhibitor | 0.108 0.036 CID_124202107 | ||
| 0.22 | 0.008 | 0.22 | HIV-1 integrase (Overall Integration) inhibitor | |||
| 0.309 | 0.097 | 0.309 | Thioredoxin glutathione reductase inhibitor | |||
| 0.286 | 0.075 | 0.326 | Spasmolytic | 0.326 0.06 CID_124202107 | CID_124202107 | |
| 0.248 | 0.038 | 0.248 | Dual specificity phosphatase inhibitor | |||
| 0.213 | 0.005 | 0.213 | HIV-1 integrase inhibitor | 0.117 0.016 CID_124202107 | ||
| 0.214 | 0.006 | 0.214 | Aldose reductase inhibitor | 0.156 0.01 CID_124202107 | ||
| 0.221 | 0.016 | 0.221 | Arachidonic acid antagonist | 0.123 0.122 CID_124202107 | ||
| 0.211 | 0.009 | 0.211 | Adenylate cyclase stimulant | 0.16 0.047 CID_124202107 | ||
| 0.212 | 0.013 | 0.212 | Breast cancer-resistant protein inhibitor | |||
| 0.25 | 0.051 | 0.389 | Peptidyltransferase inhibitor | 0.389 0.008 CID_124202107 | CID_124202107 | |
| 0.202 | 0.006 | 0.202 | Alpha tubulin antagonist | 0.048 0.044 CID_124202107 | ||
| 0.198 | 0.005 | 0.198 | Carbonic anhydrase VB inhibitor | |||
| 0.199 | 0.006 | 0.199 | Leukotriene antagonist | 0.133 0.013 CID_124202107 | ||
| 0.215 | 0.022 | 0.413 | Alkylator | 0.413 0.007 CID_124202107 | CID_124202107 | |
| 0.303 | 0.113 | 0.303 | GABA C receptor rho-3 antagonist | |||
| 0.204 | 0.014 | 0.274 | Topoisomerase II alpha inhibitor | 0.274 0.009 CID_124202107 | CID_124202107 | |
| 0.335 | 0.145 | 0.335 | DNA directed DNA polymerase inhibitor | |||
| 0.242 | 0.055 | 0.242 | RNA-directed DNA polymerase inhibitor | 0.205 0.093 CID_124202107 | ||
| 0.194 | 0.007 | 0.234 | Toll-Like receptor 4 antagonist | 0.234 0.004 CID_124202107 | CID_124202107 | |
| 0.215 | 0.029 | 0.215 | Neurotensin receptor agonist | |||
| 0.332 | 0.148 | 0.332 | DNA polymerase beta inhibitor | |||
| 0.213 | 0.03 | 0.213 | M18 aspartyl aminopeptidase inhibitor | |||
| 0.195 | 0.014 | 0.195 | Uric acid excretion stimulant | 0.181 0.016 CID_124202107 | ||
| 0.184 | 0.005 | 0.184 | Xanthine dehydrogenase inhibitor | 0.086 0.021 CID_124202107 | ||
| 0.215 | 0.036 | 0.215 | Cyclooxygenase inhibitor | 0.152 0.068 CID_124202107 | ||
| 0.186 | 0.009 | 0.186 | DOPA decarboxylase inhibitor | |||
| 0.181 | 0.005 | 0.181 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | 0.142 0.008 CID_124202107 | ||
| 0.25 | 0.079 | 0.25 | Gastrin inhibitor | |||
| 0.176 | 0.005 | 0.176 | Transcription factor AP-1 inhibitor | 0.084 0.019 CID_124202107 | ||
| 0.23 | 0.062 | 0.23 | Platelet aggregation inhibitor | |||
| 0.172 | 0.004 | 0.172 | Prostaglandin EP3 antagonist | |||
| 0.172 | 0.004 | 0.172 | Leukotriene B4 antagonist | 0.143 0.005 CID_124202107 | ||
| 0.176 | 0.011 | 0.176 | Thioredoxin inhibitor | 0.156 0.015 CID_124202107 | ||
| 0.185 | 0.026 | 0.185 | Antibacterial (Helicobacter pylori) | 0.169 0.034 CID_124202107 | ||
| 0.194 | 0.039 | 0.241 | Insulin secretagoues | 0.241 0.021 CID_124202107 | CID_124202107 | |
| 0.171 | 0.017 | 0.342 | AMP-activated protein kinase stimulant | 0.342 0.004 CID_124202107 | CID_124202107 | |
| 0.227 | 0.076 | 0.293 | Cyclic AMP phosphodiesterase inhibitor | 0.293 0.044 CID_124202107 | CID_124202107 | |
| 0.166 | 0.016 | 0.173 | Ca2+-transporting ATPase inhibitor | 0.173 0.011 CID_124202107 | CID_124202107 | |
| 0.167 | 0.019 | 0.727 | Beta glucuronidase inhibitor | 0.727 0.002 CID_124202107 | CID_124202107 | |
| 0.258 | 0.11 | 0.476 | Interleukin 2 agonist | 0.476 0.011 CID_124202107 | CID_124202107 | |
| 0.163 | 0.016 | 0.19 | Phosphofructokinase-1 inhibitor | 0.19 0.012 CID_124202107 | CID_124202107 | |
| 0.246 | 0.098 | 0.559 | Immunostimulant | 0.559 0.022 CID_124202107 | CID_124202107 | |
| 0.166 | 0.022 | 0.166 | TRPA1 agonist | |||
| 0.259 | 0.116 | 0.46 | Angiogenesis inhibitor | 0.46 0.038 CID_124202107 | CID_124202107 | |
| 0.16 | 0.018 | 0.16 | Prolactin inhibitor | |||
| 0.15 | 0.01 | 0.15 | Alcohol oxidase inhibitor | |||
| 0.162 | 0.022 | 0.262 | DNA repair enzyme inhibitor | 0.262 0.005 CID_124202107 | CID_124202107 | |
| 0.184 | 0.046 | 0.184 | MAO inhibitor | |||
| 0.145 | 0.009 | 0.145 | GABA aminotransferase inhibitor | 0.142 0.009 CID_124202107 | ||
| 0.169 | 0.034 | 0.262 | Cyclooxygenase 3 inhibitor | 0.262 0.008 CID_124202107 | CID_124202107 | |
| 0.147 | 0.012 | 0.147 | Phenylalanine 4-hydroxylase inhibitor | |||
| 0.177 | 0.044 | 0.177 | GABA C receptor rho-2 antagonist | |||
| 0.146 | 0.016 | 0.266 | Cell adhesion molecule inhibitor | 0.266 0.005 CID_124202107 | CID_124202107 | |
| 0.15 | 0.022 | 0.15 | Calcium antagonist | |||
| 0.142 | 0.015 | 0.142 | Peroxisome proliferator-activated receptor gamma agonist | |||
| 0.13 | 0.004 | 0.158 | Glucose-6-phosphate translocase inhibitor | 0.158 0.003 CID_124202107 | CID_124202107 | |
| 0.155 | 0.028 | 0.17 | Photosensitizer | 0.17 0.021 CID_124202107 | CID_124202107 | |
| 0.147 | 0.021 | 0.147 | Porphobilinogen synthase inhibitor | |||
| 0.155 | 0.029 | 0.155 | Carbonic anhydrase XV inhibitor | |||
| 0.136 | 0.011 | 0.139 | ATPase (Vacuolar H+) inhibitor | 0.139 0.01 CID_124202107 | CID_124202107 | |
| 0.164 | 0.04 | 0.164 | Aldehyde dehydrogenase inhibitor | 0.104 0.091 CID_124202107 | ||
| 0.136 | 0.012 | 0.136 | Thioredoxin reductase inhibitor | 0.114 0.019 CID_124202107 | ||
| 0.126 | 0.006 | 0.126 | Plasminogen activator inhibitor antagonist | |||
| 0.129 | 0.015 | 0.129 | Vanilloid agonist | 0.091 0.045 CID_124202107 | ||
| 0.165 | 0.051 | 0.165 | Alkaline phosphatase inhibitor | 0.16 0.053 CID_124202107 | ||
| 0.125 | 0.012 | 0.125 | NMDA receptor agonist | |||
| 0.142 | 0.029 | 0.142 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.135 0.032 CID_124202107 | ||
| 0.126 | 0.013 | 0.126 | Granulocyte macrophage colony stimulating factor agonist | |||
| 0.14 | 0.031 | 0.14 | Adenylate kinase inhibitor | |||
| 0.132 | 0.023 | 0.27 | NADH dehydrogenase inhibitor | 0.27 0.007 CID_124202107 | CID_124202107 | |
| 0.115 | 0.008 | 0.115 | Carbonic anhydrase VII inhibitor | 0.045 0.034 CID_124202107 | ||
| 0.191 | 0.084 | 0.191 | Histone acetyltransferase inhibitor | |||
| 0.173 | 0.066 | 0.336 | Thrombolytic | 0.336 0.019 CID_124202107 | CID_124202107 | |
| 0.127 | 0.021 | 0.127 | Glutamate dehydrogenase inhibitor | |||
| 0.127 | 0.021 | 0.399 | Selectin antagonist | 0.399 0.003 CID_124202107 | CID_124202107 | |
| 0.11 | 0.004 | 0.11 | Retinoid X alpha receptor agonist | |||
| 0.155 | 0.05 | 0.155 | Cyclooxygenase 2 inhibitor | 0.108 0.094 CID_124202107 | ||
| 0.111 | 0.007 | 0.111 | Aconitate hydratase inhibitor | |||
| 0.146 | 0.043 | 0.313 | Topoisomerase I inhibitor | 0.313 0.01 CID_124202107 | CID_124202107 | |
| 0.116 | 0.014 | 0.116 | Glycine receptor agonist | 0.091 0.027 CID_124202107 | ||
| 0.202 | 0.101 | 0.202 | Aryl hydrocarbon receptor agonist | |||
| 0.129 | 0.029 | 0.129 | Alcohol dehydrogenase inhibitor | 0.113 0.04 CID_124202107 | ||
| 0.138 | 0.038 | 0.138 | Caspase 3 inhibitor | |||
| 0.141 | 0.041 | 0.141 | MAO B inhibitor | |||
| 0.163 | 0.064 | 0.218 | Hexokinase inhibitor | 0.218 0.026 CID_124202107 | CID_124202107 | |
| 0.134 | 0.035 | 0.134 | Gastric antisecretory | |||
| 0.141 | 0.042 | 0.141 | Ferrochelatase inhibitor | |||
| 0.134 | 0.035 | 0.204 | Multidrug resistance-associated protein 1 inhibitor | 0.204 0.009 CID_124202107 | CID_124202107 | |
| 0.101 | 0.005 | 0.101 | Retinoid X receptor agonist | |||
| 0.104 | 0.008 | 0.104 | Exportin-1 inhibitor | |||
| 0.12 | 0.025 | 0.142 | Phosphodiesterase 6D inhibitor | 0.142 0.012 CID_124202107 | CID_124202107 | |
| 0.152 | 0.057 | 0.152 | Bone formation stimulant | 0.141 0.066 CID_124202107 | ||
| 0.132 | 0.039 | 0.132 | Bronchodilator | |||
| 0.14 | 0.048 | 0.268 | Beta amyloid protein antagonist | 0.268 0.007 CID_124202107 | CID_124202107 | |
| 0.105 | 0.015 | 0.105 | Maillard reaction inhibitor | |||
| 0.105 | 0.014 | 0.105 | NMDA receptor glycine site agonist | |||
| 0.121 | 0.031 | 0.121 | Estrogen receptor beta antagonist | |||
| 0.103 | 0.014 | 0.103 | GABA B receptor agonist | |||
| 0.095 | 0.006 | 0.095 | DNA helicase inhibitor | 0.057 0.033 CID_124202107 | ||
| 0.106 | 0.018 | 0.106 | Estrogen-related receptor beta agonist | |||
| 0.109 | 0.021 | 0.109 | Leukotriene synthesis inhibitor | |||
| 0.12 | 0.032 | 0.169 | Triose-phosphate isomerase inhibitor | 0.169 0.015 CID_124202107 | CID_124202107 | |
| 0.145 | 0.058 | 0.145 | Farnesoid X receptor antagonist | |||
| 0.11 | 0.026 | 0.11 | Myeloperoxidase inhibitor | |||
| 0.087 | 0.004 | 0.087 | Retinoic acid alpha receptor agonist | 0.036 0.033 CID_124202107 | ||
| 0.085 | 0.003 | 0.085 | Kainate receptor agonist | |||
| 0.087 | 0.007 | 0.087 | Glucose-6-phosphate isomerase inhibitor | 0.086 0.007 CID_124202107 | ||
| 0.119 | 0.04 | 0.119 | Anabolic | |||
| 0.092 | 0.014 | 0.092 | Peroxisome proliferator-activated receptor alpha agonist | |||
| 0.103 | 0.025 | 0.103 | Estrogen receptor alpha antagonist | |||
| 0.141 | 0.063 | 0.141 | Toll-Like receptor antagonist | |||
| 0.105 | 0.027 | 0.125 | Na+ K+ transporting ATPase inhibitor | 0.125 0.014 CID_124202107 | CID_124202107 | |
| 0.118 | 0.042 | 0.118 | GABA C receptor rho-1 antagonist | |||
| 0.102 | 0.026 | 0.102 | CDC25A inhibitor | |||
| 0.146 | 0.07 | 0.324 | Cell wall synthesis inhibitor | 0.324 0.009 CID_124202107 | CID_124202107 | |
| 0.087 | 0.012 | 0.087 | Glutamate (mGluR group III) agonist | |||
| 0.084 | 0.01 | 0.084 | Thromboxane synthase inhibitor | |||
| 0.137 | 0.063 | 0.165 | Interleukin 4 antagonist | 0.165 0.038 CID_124202107 | CID_124202107 | |
| 0.131 | 0.058 | 0.131 | Papain-like protease (SARS coronavirus) inhibitor | |||
| 0.133 | 0.06 | 0.133 | Cathepsin H inhibitor | |||
| 0.077 | 0.005 | 0.077 | Catechol O-methyltransferase inhibitor | |||
| 0.076 | 0.004 | 0.076 | Retinoid X gamma receptor agonist | |||
| 0.119 | 0.048 | 0.119 | Electron transport complex I inhibitor | |||
| 0.079 | 0.008 | 0.083 | Factor III inhibitor | 0.083 0.007 CID_124202107 | CID_124202107 | |
| 0.091 | 0.02 | 0.091 | Purinergic P2X1 antagonist | |||
| 0.076 | 0.009 | 0.076 | Pregnane X receptor antagonist | |||
| 0.083 | 0.015 | 0.083 | Transcription factor RelA inhibitor | |||
| 0.075 | 0.008 | 0.075 | Fumarate hydratase inhibitor | |||
| 0.088 | 0.02 | 0.088 | Prostaglandin antagonist | |||
| 0.072 | 0.004 | 0.072 | Leukotriene B4 receptor 1 antagonist | 0.031 0.017 CID_124202107 | ||
| 0.081 | 0.014 | 0.081 | Heme oxygenase stimulant | 0.058 0.052 CID_124202107 | ||
| 0.195 | 0.128 | 0.195 | Neuropeptide Y2 antagonist | |||
| 0.086 | 0.021 | 0.086 | Estrogen agonist | 0.058 0.031 CID_124202107 | ||
| 0.073 | 0.007 | 0.073 | Prostaglandin agonist | |||
| 0.102 | 0.037 | 0.178 | Transcription factor NF kappa B stimulant | 0.178 0.011 CID_124202107 | CID_124202107 | |
| 0.119 | 0.054 | 0.119 | GABA C receptor antagonist | |||
| 0.144 | 0.08 | 0.144 | Cytidine deaminase inhibitor | |||
| 0.104 | 0.041 | 0.104 | Bile acid receptor antagonist | |||
| 0.068 | 0.004 | 0.068 | Retinoid X beta receptor agonist | |||
| 0.212 | 0.149 | 0.212 | Prostaglandin dehydrogenase inhibitor | |||
| 0.074 | 0.011 | 0.074 | Leukotriene C antagonist | |||
| 0.086 | 0.023 | 0.086 | CDC25B inhibitor | |||
| 0.079 | 0.017 | 0.14 | Phosphorylase inhibitor | 0.14 0.008 CID_124202107 | CID_124202107 | |
| 0.111 | 0.049 | 0.111 | Creatine kinase inhibitor | |||
| 0.066 | 0.004 | 0.066 | Retinoid X receptor antagonist | |||
| 0.179 | 0.118 | 0.179 | ErbB-1 antagonist | |||
| 0.071 | 0.011 | 0.192 | Heparanase inhibitor | 0.192 0.002 CID_124202107 | CID_124202107 | |
| 0.124 | 0.064 | 0.124 | Adenylate cyclase inhibitor | |||
| 0.085 | 0.024 | 0.085 | Biliverdin reductase inhibitor | |||
| 0.121 | 0.06 | 0.121 | Interleukin 8 antagonist | |||
| 0.085 | 0.027 | 0.085 | Peroxisome proliferator-activated receptor gamma antagonist | |||
| 0.109 | 0.052 | 0.326 | UDP-glucose 4-epimerase inhibitor | 0.326 0.009 CID_124202107 | CID_124202107 | |
| 0.084 | 0.027 | 0.084 | Carbamoyl phosphate synthetase inhibitor | |||
| 0.061 | 0.005 | 0.061 | Retinoic acid receptor agonist | |||
| 0.06 | 0.004 | 0.06 | Retinoic acid alpha receptor antagonist | |||
| 0.096 | 0.041 | 0.096 | Inducible nitric-oxide synthase inhibitor | |||
| 0.062 | 0.007 | 0.062 | Glutamate (mGluR8) agonist | |||
| 0.08 | 0.025 | 0.136 | Neuraminidase (influenza) inhibitor | 0.136 0.009 CID_124202107 | CID_124202107 | |
| 0.11 | 0.056 | 0.11 | Urease inhibitor | |||
| 0.126 | 0.072 | 0.126 | Acetylcholinesterase inhibitor | |||
| 0.081 | 0.027 | 0.081 | Glutamate (mGluR7) antagonist | |||
| 0.106 | 0.053 | 0.106 | Sphingomyelinase inhibitor | 0.102 0.057 CID_124202107 | ||
| 0.073 | 0.022 | 0.073 | Prostaglandin E2 antagonist | |||
| 0.069 | 0.019 | 0.069 | Ryanodine receptor antagonist | |||
| 0.054 | 0.004 | 0.054 | Retinoic acid receptor antagonist | |||
| 0.054 | 0.005 | 0.054 | Retinoid X alpha receptor antagonist | |||
| 0.121 | 0.071 | 0.121 | Sphingosine 1-phosphate receptor 4 antagonist | |||
| 0.091 | 0.042 | 0.091 | D-Ala-D-Ala ligase inhibitor | |||
| 0.077 | 0.028 | 0.112 | Neuraminidase inhibitor | 0.112 0.012 CID_124202107 | CID_124202107 | |
| 0.096 | 0.048 | 0.263 | Antineoplastic antibiotic | 0.263 0.013 CID_124202107 | CID_124202107 | |
| 0.11 | 0.065 | 0.131 | Acetylcholine release stimulant | 0.131 0.033 CID_124202107 | CID_124202107 | |
| 0.24 | 0.194 | 0.24 | Transcription factor inhibitor | |||
| 0.126 | 0.083 | 0.126 | Cytokine production inhibitor | |||
| 0.054 | 0.011 | 0.054 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | |||
| 0.066 | 0.024 | 0.066 | Thromboxane A2 antagonist | |||
| 0.046 | 0.004 | 0.046 | Retinoid X gamma receptor antagonist | |||
| 0.06 | 0.018 | 0.06 | Adenylate cyclase 1 inhibitor | |||
| 0.068 | 0.027 | 0.068 | Thromboxane antagonist | |||
| 0.062 | 0.021 | 0.062 | Lysophosphatidic acid 3 receptor antagonist | |||
| 0.049 | 0.008 | 0.049 | Prostaglandin EP4 antagonist | |||
| 0.082 | 0.042 | 0.116 | Histone deacetylase SIRT1 stimulant | 0.116 0.019 CID_124202107 | CID_124202107 | |
| 0.082 | 0.042 | 0.116 | Histone deacetylase stimulant | 0.116 0.019 CID_124202107 | CID_124202107 | |
| 0.046 | 0.007 | 0.046 | Prostaglandin EP2 agonist | |||
| 0.06 | 0.021 | 0.06 | Squalene epoxidase inhibitor | 0.053 0.029 CID_124202107 | ||
| 0.073 | 0.034 | 0.073 | Glutamate (mGluR6) antagonist | |||
| 0.049 | 0.011 | 0.049 | Leukotriene C4 antagonist | |||
| 0.048 | 0.009 | 0.048 | Tubulin agonist | 0.04 0.015 CID_124202107 | ||
| 0.072 | 0.035 | 0.072 | Protease 3C (Human rhinovirus) inhibitor | |||
| 0.057 | 0.021 | 0.057 | Estradiol 17 beta-dehydrogenase inhibitor | |||
| 0.043 | 0.007 | 0.043 | Prostaglandin E2 agonist | |||
| 0.041 | 0.005 | 0.041 | Leukotriene B4 receptor 2 antagonist | 0.025 0.012 CID_124202107 | ||
| 0.039 | 0.004 | 0.039 | Retinoic acid gamma receptor agonist | |||
| 0.043 | 0.009 | 0.043 | NMDA 2D receptor antagonist | |||
| 0.058 | 0.025 | 0.058 | Vanilloid 2 antagonist | |||
| 0.082 | 0.05 | 0.082 | Metalloproteinase-2 inhibitor | |||
| 0.044 | 0.013 | 0.044 | Integrin alpha1beta1 antagonist | |||
| 0.035 | 0.005 | 0.035 | ICAM 1 antagonist | |||
| 0.046 | 0.017 | 0.046 | Inosine monophosphate dehydrogenase inhibitor | |||
| 0.035 | 0.006 | 0.035 | Inosine monophosphate dehydrogenase 2 inhibitor | |||
| 0.044 | 0.015 | 0.044 | RNA-directed RNA polymerase inhibitor | |||
| 0.049 | 0.02 | 0.049 | Dihydrofolate reductase inhibitor | |||
| 0.056 | 0.027 | 0.056 | Glycine transporter 2 inhibitor | |||
| 0.181 | 0.153 | 0.181 | 5 Hydroxytryptamine 1E antagonist | |||
| 0.076 | 0.047 | 0.076 | Cathepsin G inhibitor | |||
| 0.033 | 0.005 | 0.033 | Retinoic acid beta receptor agonist | |||
| 0.062 | 0.035 | 0.062 | Botulinum neurotoxin type A inhibitor | |||
| 0.039 | 0.011 | 0.039 | Glutamate (mGluR3) agonist | |||
| 0.075 | 0.048 | 0.089 | Lipase inhibitor | 0.089 0.035 CID_124202107 | CID_124202107 | |
| 0.04 | 0.013 | 0.04 | ATP citrate lysase inhibitor | |||
| 0.034 | 0.009 | 0.034 | Prostaglandin H2 antagonist | |||
| 0.049 | 0.025 | 0.066 | Neuraminidase (Influenza A) inhibitor | 0.066 0.009 CID_124202107 | CID_124202107 | |
| 0.029 | 0.005 | 0.029 | Retinoid X beta receptor antagonist | |||
| 0.035 | 0.011 | 0.035 | LFA antagonist | |||
| 0.058 | 0.034 | 0.058 | Acyl-CoA dehydrogenase inhibitor | |||
| 0.04 | 0.017 | 0.04 | Peroxisome proliferator-activated receptor delta agonist | |||
| 0.041 | 0.017 | 0.041 | Prostacyclin antagonist | |||
| 0.037 | 0.015 | 0.037 | Prostaglandin D2 agonist | |||
| 0.052 | 0.03 | 0.052 | Topoisomerase II beta inhibitor | |||
| 0.24 | 0.217 | 0.24 | Calcium channel L-type activator | |||
| 0.092 | 0.07 | 0.092 | MAO A inhibitor | |||
| 0.064 | 0.042 | 0.091 | Nitric oxide donor | 0.091 0.014 CID_124202107 | CID_124202107 | |
| 0.041 | 0.019 | 0.041 | Vanilloid 3 antagonist | |||
| 0.038 | 0.017 | 0.038 | HMG CoA reductase inhibitor | |||
| 0.087 | 0.068 | 0.096 | Glutamate release inhibitor | 0.096 0.05 CID_124202107 | CID_124202107 | |
| 0.056 | 0.038 | 0.097 | Adenine nucleotide translocase inhibitor | 0.097 0.005 CID_124202107 | CID_124202107 | |
| 0.038 | 0.021 | 0.038 | Phosphoglycerate kinase inhibitor | |||
| 0.021 | 0.004 | 0.021 | Glutamate (mGluR6) agonist | |||
| 0.031 | 0.014 | 0.031 | Kynurenine 3 monooxygenase inhibitor | |||
| 0.044 | 0.027 | 0.044 | Guanylate cyclase inhibitor | 0.041 0.032 CID_124202107 | ||
| 0.142 | 0.126 | 0.142 | Catenin beta inhibitor | |||
| 0.019 | 0.004 | 0.019 | Retinoic acid beta receptor antagonist | |||
| 0.029 | 0.014 | 0.029 | Methionyl aminopeptidase 2 inhibitor | |||
| 0.028 | 0.014 | 0.028 | Thyroid hormone agonist | |||
| 0.123 | 0.109 | 0.381 | Hemostatic | 0.381 0.009 CID_124202107 | CID_124202107 | |
| 0.036 | 0.022 | 0.036 | Estrogen receptor alpha agonist | |||
| 0.055 | 0.041 | 0.055 | Argininosuccinate synthase inhibitor | |||
| 0.066 | 0.052 | 0.066 | MDM2 inhibitor | |||
| 0.047 | 0.033 | 0.047 | Potassium channel Kv1.3 blocker | |||
| 0.025 | 0.012 | 0.025 | Prostaglandin F2 alpha agonist | |||
| 0.024 | 0.012 | 0.024 | Integrin beta5 antagonist | |||
| 0.032 | 0.019 | 0.032 | Lysophosphatidic acid 2 receptor antagonist | |||
| 0.017 | 0.005 | 0.017 | Retinoic acid receptor gamma antagonist | |||
| 0.048 | 0.036 | 0.048 | Dopamine beta hydroxylase inhibitor | |||
| 0.04 | 0.028 | 0.04 | Dopamine D5 agonist | |||
| 0.037 | 0.027 | 0.037 | Farnesoid X receptor agonist | |||
| 0.033 | 0.023 | 0.033 | Estrogen-related receptor alpha antagonist | |||
| 0.016 | 0.006 | 0.016 | Integrin beta2 antagonist | |||
| 0.091 | 0.081 | 0.091 | Glutamate (mGluR7) agonist | |||
| 0.038 | 0.029 | 0.038 | GABA uptake inhibitor | |||
| 0.018 | 0.009 | 0.018 | Prostaglandin EP4 agonist | |||
| 0.026 | 0.018 | 0.026 | Leukotriene D4 antagonist | |||
| 0.129 | 0.121 | 0.13 | CF transmembrane conductance regulator agonist | 0.13 0.119 CID_124202107 | CID_124202107 | |
| 0.015 | 0.007 | 0.015 | Integrin alphaLbeta2 antagonist | |||
| 0.068 | 0.061 | 0.068 | Metalloproteinase-9 inhibitor | |||
| 0.052 | 0.045 | 0.052 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.05 0.049 CID_124202107 | ||
| 0.032 | 0.027 | 0.032 | Glutamate (mGluR4) agonist | |||
| 0.057 | 0.052 | 0.057 | Prostaglandin F2 alpha antagonist | |||
| 0.135 | 0.13 | 0.135 | Lipocortins synthesis antagonist | |||
| 0.065 | 0.06 | 0.065 | Aminopeptidase I inhibitor | |||
| 0.049 | 0.045 | 0.075 | Alpha-mannosidase inhibitor | 0.075 0.014 CID_124202107 | CID_124202107 | |
| 0.015 | 0.011 | 0.015 | Thromboxane A2 agonist | |||
| 0.056 | 0.051 | 0.056 | NMDA 2C receptor antagonist | |||
| 0.086 | 0.082 | 0.1 | Interleukin 12 antagonist | 0.1 0.053 CID_124202107 | CID_124202107 | |
| 0.023 | 0.019 | 0.023 | NMDA receptor glycine site antagonist | |||
| 0.083 | 0.079 | 0.083 | Aminopeptidase B inhibitor | |||
| 0.036 | 0.033 | 0.036 | Membrane dipeptidase inhibitor | |||
| 0.047 | 0.044 | 0.047 | CD45 antagonist | |||
| 0.018 | 0.016 | 0.035 | Antibiotic Anthracycline-like | 0.035 0.003 CID_124202107 | CID_124202107 | |
| 0.096 | 0.093 | 0.096 | Proteasome inhibitor | |||
| 0.014 | 0.012 | 0.014 | Prostacyclin agonist | |||
| 0.072 | 0.071 | 0.094 | Glycine receptor antagonist | 0.094 0.039 CID_124202107 | CID_124202107 | |
| 0.023 | 0.025 | 0.03 | Vanilloid 2 agonist | 0.03 0.01 CID_124202107 | CID_124202107 | |
| 0.012 | 0.021 | 0.017 | Ileal bile acid transport inhibitor | 0.017 0.011 CID_124202107 | CID_124202107 | |
| 0.022 | 0.033 | 0.073 | Squalene synthetase inhibitor | 0.073 0.009 CID_124202107 | CID_124202107 | |
| 0.013 | 0.025 | 0.017 | Telomerase stimulant | 0.017 0.012 CID_124202107 | CID_124202107 | |
| 0.047 | 0.059 | 0.063 | Carbonic anhydrase inhibitor | 0.063 0.044 CID_124202107 | CID_124202107 | |
| 0.022 | 0.04 | 0.047 | Arginase inhibitor | 0.047 0.017 CID_124202107 | CID_124202107 | |
| 0.034 | 0.053 | 0.065 | Mannosidase inhibitor | 0.065 0.014 CID_124202107 | CID_124202107 | |
| 0.105 | 0.125 | 0.123 | Neurotrophic factor | 0.123 0.09 CID_124202107 | CID_124202107 | |
| 0.017 | 0.045 | 0.071 | Sodium/glucose cotransporter 2 inhibitor | 0.071 0.004 CID_124202107 | CID_124202107 | |
| 0.033 | 0.062 | 0.059 | Microtubule stabilization | 0.059 0.015 CID_124202107 | CID_124202107 | |
| 0.028 | 0.063 | 0.06 | Carbonic anhydrase IX inhibitor | 0.06 0.037 CID_124202107 | CID_124202107 | |
| 0.018 | 0.053 | 0.057 | Sodium/glucose cotransporter inhibitor | 0.057 0.004 CID_124202107 | CID_124202107 | |
| 0.024 | 0.067 | 0.088 | Carbonic anhydrase XII inhibitor | 0.088 0.023 CID_124202107 | CID_124202107 | |
| 0.031 | 0.075 | 0.107 | Protein 50S ribosomal subunit inhibitor | 0.107 0.012 CID_124202107 | CID_124202107 | |
| 0.045 | 0.109 | 0.064 | Lipocortins synthesis agonist | 0.064 0.029 CID_124202107 | CID_124202107 | |
| 0.002 | 0.071 | 0.012 | Antibiotic Macrolide-like | 0.012 0.011 CID_124202107 | CID_124202107 | |
| 0.009 | 0.079 | 0.019 | Corticosteroid-like | 0.019 0.018 CID_124202107 | CID_124202107 | |
| 0.107 | 0.18 | 0.151 | Interleukin 6 antagonist | 0.151 0.088 CID_124202107 | CID_124202107 | |
| 0.018 | 0.101 | 0.034 | Toll-Like receptor 4 agonist | 0.034 0.008 CID_124202107 | CID_124202107 | |
| 0.053 | 0.165 | 0.128 | DNA intercalator | 0.128 0.053 CID_124202107 | CID_124202107 | |
| 0.02 | 0.148 | 0.069 | Antibiotic Aminoglycoside-like | 0.069 0.006 CID_124202107 | CID_124202107 | |
| 0.01 | 0.167 | 0.029 | 1,3-Beta-glucan synthase inhibitor | 0.029 0.019 CID_124202107 | CID_124202107 | |
| 0.009 | 0.189 | 0.043 | Protein 30S ribosomal subunit inhibitor | 0.043 0.009 CID_124202107 | CID_124202107 | |
| 0.094 | 0.353 | 0.139 | CC chemokine 6 receptor antagonist | 0.139 0.042 CID_124202107 | CID_124202107 | |
| 0.036 | 0.38 | 0.185 | Anticoagulant | 0.185 0.059 CID_124202107 | CID_124202107 | |
| 0.018 | 0.405 | 0.068 | Factor IXa inhibitor | 0.068 0.022 CID_124202107 | CID_124202107 | |
| 0.052 | 0.566 | 0.396 | Immunomodulator | 0.396 0.045 CID_124202107 | CID_124202107 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |